PMC17 SHOULD INDIRECT COSTS OF ILLNESS BE INCLUDED IN PHARMACOECONOMIC ANALYSIS- SURVEY AMONG POLISH DECISION MAKERS AND EXPERTS
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74919-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)74919-6/fulltext
Title :
PMC17 SHOULD INDIRECT COSTS OF ILLNESS BE INCLUDED IN PHARMACOECONOMIC ANALYSIS- SURVEY AMONG POLISH DECISION MAKERS AND EXPERTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74919-6&doi=10.1016/S1098-3015(10)74919-6
First page :
Section Title :
Open access? :
No
Section Order :
841